BREYNA is a Respiratory (inhalation) Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Budesonide; Formoterol Fumarate.
| Product ID | 0378-7502_dc529fc4-bddb-4673-8202-dc401f86166f |
| NDC | 0378-7502 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BREYNA |
| Generic Name | Budesonide And Formoterol Fumarate |
| Dosage Form | Aerosol, Metered |
| Route of Administration | RESPIRATORY (INHALATION) |
| Marketing Start Date | 2022-04-01 |
| Marketing Category | ANDA / |
| Application Number | ANDA211699 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | BUDESONIDE; FORMOTEROL FUMARATE |
| Active Ingredient Strength | 80 ug/1; ug/1 |
| Pharm Classes | Adrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-7502 | BREYNA | Budesonide and Formoterol Fumarate |
| 0378-7503 | BREYNA | Budesonide and Formoterol Fumarate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() BREYNA 97936938 not registered Live/Pending |
Mylan Pharmaceuticals Inc. 2023-05-15 |
![]() BREYNA 97351431 not registered Live/Pending |
Mylan Pharmaceuticals, Inc. 2022-04-07 |
![]() BREYNA 88634036 not registered Live/Pending |
Mylan Pharmaceuticals, Inc. 2019-09-27 |
![]() BREYNA 87930172 not registered Live/Pending |
Mylan Pharmaceuticals, Inc 2018-05-21 |
![]() BREYNA 87241508 not registered Dead/Abandoned |
Mylan Pharmaceuticals, Inc. 2016-11-18 |